Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms

Diego Cantoni, Nigel Temperton, Martin Mayora Neto et al.|Vaccines|2022

Cited by 14